Log in

LON:RENX - Renalytix Ai Share Price, Forecast & News

GBX 220
0.00 (0.00 %)
(As of 03/31/2020 03:42 AM ET)
Today's Range
211
Now: GBX 220
230
50-Day Range
173.50
MA: GBX 286.29
345
52-Week Range
115
Now: GBX 220
370
Volume2,313 shs
Average VolumeN/A
Market Capitalization£130.72 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Renalytix AI plc develops artificial intelligence (AI) enabled clinical decision support solutions for kidney disease. It is developing KidneyIntelX, an AI-enabled, clinical-laboratory based solution that supports physician decision making by improving identification, prediction, and risk stratification of patients with kidney disease. The company is based in Cardiff, the United Kingdom. Renalytix AI plc (AIM:RENX) operates independently of EKF Diagnostics Holdings plc as of November 2, 2018.
Read More

Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£105,000.00
Cash FlowGBX 35.50 per share
Book ValueGBX 70.30 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap£130.72 million
Next Earnings DateN/A
OptionableNot Optionable

Receive RENX News and Ratings via Email

Sign-up to receive the latest news and ratings for RENX and its competitors with MarketBeat's FREE daily newsletter.


Renalytix Ai (LON:RENX) Frequently Asked Questions

How has Renalytix Ai's stock been impacted by COVID-19 (Coronavirus)?

Renalytix Ai's stock was trading at GBX 275 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, RENX stock has decreased by 20.0% and is now trading at GBX 220. View which stocks have been mosted impacted by Coronavirus.

Has Renalytix Ai been receiving favorable news coverage?

News headlines about RENX stock have trended somewhat negative on Tuesday, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Renalytix Ai earned a media sentiment score of -1.4 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news aboutRenalytix Ai.

Who are some of Renalytix Ai's key competitors?

Who are Renalytix Ai's key executives?

Renalytix Ai's management team includes the following people:
  • Mr. James R. McCullough, CEO & Director (Age 51)
  • Mr. O. James Sterling III, Chief Financial Officer
  • Dr. Sally Bowden, Chief Operating Officer
  • Fergus Fleming, CTO & Director
  • Salim Hamir, Company Sec.

What is Renalytix Ai's stock symbol?

Renalytix Ai trades on the London Stock Exchange (LON) under the ticker symbol "RENX."

How do I buy shares of Renalytix Ai?

Shares of RENX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Renalytix Ai's stock price today?

One share of RENX stock can currently be purchased for approximately GBX 220.

How big of a company is Renalytix Ai?

Renalytix Ai has a market capitalization of £130.72 million and generates £105,000.00 in revenue each year.  View additional information about Renalytix Ai.

What is Renalytix Ai's official website?

The official website for Renalytix Ai is http://www.renalytixai.com/.


MarketBeat Community Rating for Renalytix Ai (LON RENX)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  23 (Vote Outperform)
Underperform Votes:  16 (Vote Underperform)
Total Votes:  39
MarketBeat's community ratings are surveys of what our community members think about Renalytix Ai and other stocks. Vote "Outperform" if you believe RENX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RENX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel